Edwards Lifesciences (EW) News Today → WARNING about the death of the U.S. dollar… (From Colonial Metals) (Ad) Free EW Stock Alerts $87.04 -0.94 (-1.07%) (As of 05/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 28 at 2:22 PM | marketbeat.comEdwards Lifesciences (NYSE:EW) Shares Down 1.4% Edwards Lifesciences (NYSE:EW) Shares Down 1.4%May 28 at 1:32 PM | marketbeat.comEdmond DE Rothschild Holding S.A. Raises Position in Edwards Lifesciences Co. (NYSE:EW)Edmond DE Rothschild Holding S.A. grew its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 107.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 96,273 shares of the medical researMay 27 at 12:20 PM | marketbeat.comEdwards Lifesciences (NYSE:EW) Trading 0.6% Higher Edwards Lifesciences (NYSE:EW) Shares Up 0.6%May 27 at 10:53 AM | marketbeat.comHsbc Holdings PLC Has $123.35 Million Holdings in Edwards Lifesciences Co. (NYSE:EW)Hsbc Holdings PLC grew its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 32.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,616,969 shares of the medical research company's stock after purchasingMay 26 at 6:55 AM | marketbeat.comCorient Private Wealth LLC Sells 13,440 Shares of Edwards Lifesciences Co. (NYSE:EW)Corient Private Wealth LLC lowered its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 8.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 137,831 shares of the medical research company's stock after seMay 25 at 10:23 PM | marketbeat.comPrimecap Management Co. CA Sells 35,000 Shares of Edwards Lifesciences Co. (NYSE:EW)Primecap Management Co. CA decreased its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 1.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,901,000 shares of the medical research company's stock after selMay 24, 2024 | marketbeat.comFirst Trust Bank Ltd. Acquires New Holdings in Edwards Lifesciences Co. (NYSE:EW)First Trust Bank Ltd. purchased a new position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 27,648 shares of the medical research company's stock, valuedMay 24, 2024 | marketbeat.comEdwards Lifesciences (NYSE:EW) Trading Up 0.5%Edwards Lifesciences (NYSE:EW) Stock Price Up 0.5%May 23, 2024 | marketbeat.comEdwards Lifesciences (NYSE:EW) Shares Down 1.7% Edwards Lifesciences (NYSE:EW) Trading Down 1.7%May 23, 2024 | marketbeat.comDai ichi Life Insurance Company Ltd Sells 65,703 Shares of Edwards Lifesciences Co. (NYSE:EW)Dai ichi Life Insurance Company Ltd reduced its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 51.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 61,320 shares of the medical research company's stock after selling 65May 23, 2024 | americanbankingnews.comEdwards Lifesciences (NYSE:EW) Raised to "Buy" at CitigroupMay 22, 2024 | msn.comCitigroup Upgrades Edwards Lifesciences (EW)May 22, 2024 | marketbeat.comEdwards Lifesciences (NYSE:EW) Trading Up 0.7%Edwards Lifesciences (NYSE:EW) Stock Price Up 0.7%May 22, 2024 | marketbeat.com12,552 Shares in Edwards Lifesciences Co. (NYSE:EW) Bought by Quest Partners LLCQuest Partners LLC bought a new stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 12,552 shares of the medical research company's stock, valued atMay 22, 2024 | marketbeat.comEdwards Lifesciences (NYSE:EW) Lifted to Buy at CitigroupCitigroup upgraded Edwards Lifesciences from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $98.00 to $105.00 in a report on Wednesday.May 22, 2024 | insidertrades.comEdwards Lifesciences Co. (NYSE:EW) CFO Sells $508,781.25 in StockMay 21, 2024 | marketbeat.comCentral Valley Advisors LLC Takes $956,000 Position in Edwards Lifesciences Co. (NYSE:EW)Central Valley Advisors LLC acquired a new position in Edwards Lifesciences Co. (NYSE:EW - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 12,538 shares of the medical research company's stock, valued at approximateMay 21, 2024 | marketbeat.comInsider Selling: Edwards Lifesciences Co. (NYSE:EW) CFO Sells 5,625 Shares of StockEdwards Lifesciences Co. (NYSE:EW - Get Free Report) CFO Scott B. Ullem sold 5,625 shares of the company's stock in a transaction that occurred on Tuesday, May 21st. The shares were sold at an average price of $90.45, for a total value of $508,781.25. Following the completion of the sale, the chief financial officer now directly owns 30,561 shares in the company, valued at approximately $2,764,242.45. The transaction was disclosed in a filing with the SEC, which is accessible through this link.May 20, 2024 | finance.yahoo.comA fantastic week for Edwards Lifesciences Corporation's (NYSE:EW) 84% institutional owners, one-year returns continue to impressMay 20, 2024 | markets.businessinsider.comRobust Growth and R&D Focus Solidify Buy Rating for Edwards LifesciencesMay 20, 2024 | marketbeat.comPNC Financial Services Group Inc. Sells 44,738 Shares of Edwards Lifesciences Co. (NYSE:EW)PNC Financial Services Group Inc. trimmed its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 6.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 677,251 shMay 19, 2024 | marketbeat.comING Groep NV Trims Stake in Edwards Lifesciences Co. (NYSE:EW)ING Groep NV lessened its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 46.3% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 113,532 shares of the medical research company's stock after sellingMay 18, 2024 | marketbeat.comJackson Square Partners LLC Sells 16,594 Shares of Edwards Lifesciences Co. (NYSE:EW)Jackson Square Partners LLC decreased its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 12.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 117,913 shares of the medical research companMay 18, 2024 | marketbeat.comFiera Capital Corp Has $67.79 Million Stock Position in Edwards Lifesciences Co. (NYSE:EW)Fiera Capital Corp lifted its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 31.4% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 889,064 shares of the medical research company's stock after buying an additioMay 16, 2024 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Acquired by EFG Asset Management North America Corp.EFG Asset Management North America Corp. increased its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 122.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 16,767 shares of the mMay 16, 2024 | benzinga.comEdwards Lifesciences's Options: A Look at What the Big Money is ThinkingMay 16, 2024 | marketbeat.comEdwards Lifesciences Q1 Earnings TranscriptMay 15, 2024 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Short Interest Up 30.5% in AprilEdwards Lifesciences Co. (NYSE:EW - Get Free Report) was the recipient of a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 9,630,000 shares, a growth of 30.5% from the April 15th total of 7,380,000 shares. Approximately 1.6% of the shares of the stock are sold short. Based on an average daily volume of 3,550,000 shares, the short-interest ratio is presently 2.7 days.May 15, 2024 | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Has $43.76 Million Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 6.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 598,326 shares of the medical research company's stockMay 15, 2024 | msn.comDeutsche Bank Upgrades Edwards Lifesciences (EW)May 14, 2024 | marketbeat.comCCLA Investment Management Sells 1,279,930 Shares of Edwards Lifesciences Co. (NYSE:EW)CCLA Investment Management lessened its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 99.9% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,395 shares of the medical research company's stock after selling 1,279,9May 14, 2024 | finance.yahoo.comIndian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust ComplaintMay 14, 2024 | marketbeat.comEdwards Lifesciences (NYSE:EW) Upgraded at Deutsche Bank AktiengesellschaftDeutsche Bank Aktiengesellschaft upgraded shares of Edwards Lifesciences from a "hold" rating to a "buy" rating in a research note on Tuesday.May 14, 2024 | insidertrades.comInsider Selling: Edwards Lifesciences Co. (NYSE:EW) VP Sells $439,050.00 in StockMay 13, 2024 | marketbeat.comInsider Selling: Edwards Lifesciences Co. (NYSE:EW) VP Sells 5,000 Shares of StockEdwards Lifesciences Co. (NYSE:EW - Get Free Report) VP Donald E. Bobo, Jr. sold 5,000 shares of the business's stock in a transaction on Friday, May 10th. The shares were sold at an average price of $87.81, for a total transaction of $439,050.00. Following the sale, the vice president now owns 47,750 shares of the company's stock, valued at $4,192,927.50. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.May 13, 2024 | msn.comIndia's Meril files EU antitrust complaint against Edwards: reportMay 13, 2024 | sg.finance.yahoo.comEdwards Lifesciences hit with Meril's EU antitrust complaintMay 11, 2024 | finance.yahoo.comInvestors in Edwards Lifesciences (NYSE:EW) have seen respectable returns of 50% over the past five yearsMay 11, 2024 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Los Angeles Capital Management LLCLos Angeles Capital Management LLC decreased its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 92.4% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 8,479 shares of the medical research company's stock afteMay 10, 2024 | insidertrades.comEdwards Lifesciences Co. (NYSE:EW) VP Sells $73,359.20 in StockMay 9, 2024 | marketbeat.comGDS Wealth Management Buys 90,328 Shares of Edwards Lifesciences Co. (NYSE:EW)GDS Wealth Management grew its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 98.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 182,209 shares of the medical research company's stock afteMay 9, 2024 | seekingalpha.comEdwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade)May 8, 2024 | finance.yahoo.comEdwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance DurabilityMay 8, 2024 | marketbeat.comNational Bank of Canada FI Raises Position in Edwards Lifesciences Co. (NYSE:EW)National Bank of Canada FI lifted its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 4.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 214,861 shares of the medical research company's stock aMay 8, 2024 | insidertrades.comEdwards Lifesciences Co. (NYSE:EW) CEO Buys $49,729.20 in StockMay 7, 2024 | marketbeat.comInsider Buying: Edwards Lifesciences Co. (NYSE:EW) CEO Buys 580 Shares of StockEdwards Lifesciences Co. (NYSE:EW - Get Free Report) CEO Bernard J. Zovighian purchased 580 shares of the business's stock in a transaction dated Monday, May 6th. The shares were purchased at an average price of $85.74 per share, for a total transaction of $49,729.20. Following the acquisition, the chief executive officer now directly owns 3,268 shares of the company's stock, valued at $280,198.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.May 7, 2024 | markets.businessinsider.comAssessing Edwards Lifesciences: Insights From 11 Financial AnalystsMay 7, 2024 | marketbeat.comEdwards Lifesciences (NYSE:EW) Price Target Raised to $101.00Barclays boosted their target price on Edwards Lifesciences from $100.00 to $101.00 and gave the company an "overweight" rating in a research report on Tuesday.May 7, 2024 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by M&T Bank CorpM&T Bank Corp lessened its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 28.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 71,727 shares of the medical research company's stock after selling 29,194 shares duMay 6, 2024 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Purchased by Spire Wealth ManagementSpire Wealth Management raised its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 40.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 81,351 shares of the medical research co Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address WARNING about the death of the U.S. dollar… (Ad)Where do you turn during times of economic uncertainty? Many elites trust storing their wealth in gold (which has historically boomed when the dollar’s value has plummeted!) Get Colonial Metals' new Precious Metals Investment Guide. EW Media Mentions By Week EW Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EW News Sentiment▼0.930.87▲Average Medical News Sentiment EW News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EW Articles This Week▼2111▲EW Articles Average Week Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Abbott Laboratories News Intuitive Surgical News Stryker News Boston Scientific News Medtronic News Becton, Dickinson and Company News DexCom News IDEXX Laboratories News ResMed News STERIS News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:EW) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaWARNING about the death of the U.S. dollar…Colonial MetalsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersWall Street Legend Warns: "A Strange Day Is Coming to America"Chaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edwards Lifesciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
